MEI Pharma (MEIP) and Kyowa Kirin Reports Data From the Ongoing Global Phase 2 TIDAL Study Evaluating Zandelisib

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. IBM
2. PRIM
3. META
4. ABBV
5. NAVN
6. CNC
7. KFY
8. SPY
9. MU
10. DPZ

Go back to MEI Pharma (MEIP) and Kyowa Kirin Reports Data From the Ongoing Global Phase 2 TIDAL Study Evaluating Zandelisib
MEI PHARM (NASDAQ: MEIP) Delayed: 3.07 --0 (-0%)
Previous Close $3.07    52 Week High $2.28 
Open $3.07    52 Week Low $0.87 
Day High $3.07    P/E N/A 
Day Low $3.07    EPS $-0.88 
Volume 108